24/11/2025 - General information
The new edition of the Highly Cited Researchers ranking, produced by Clarivate, has selected 6,868 researchers worldwide who have demonstrated significant influence in their research fields over the past eleven years. Two researchers from the Hospital del Mar Research Institute, Dr Jordi Alonso and Dr Joaquim Bellmunt, are once again included in the ranking. The researchers featured in the ranking work across around sixty countries. The United States leads the list, followed by China and the United Kingdom. Only around ninety of the selected researchers work in institutions in Spain.
18/11/2025 - General information
Solidarity, through La Marató de 3Cat, continues to drive research. The 10 million euros raised in the latest edition, dedicated to respiratory diseases, will be used to fund 36 research projects from sixty research groups. Among them are two projects led by researchers from the Hospital del Mar Research Institute and Hospital del Mar. One of the projects, led by Dr. Joan Ramon Masclans, head of the Intensive Care Medicine Service at Hospital del Mar and coordinator of the Critical Illness Research Group at the HMRIB, will focus on predicting treatment response in patients with acute hypoxemic respiratory failure treated with high-flow nasal cannula, using omics and clinical data. To do so, they will receive nearly 300,000 euros. The project also involves the Institute for Bioengineering of Catalonia (IBEC).
17/11/2025 - General information
Dr José Yélamos López has received the Carmen Delgado/Miguel Pérez Mateo Grant in the basic research category. The award ceremony for the grant, worth 100,000 euros, took place on 5 November. These grants are awarded by the Pancreatic Cancer Association, in collaboration with the Spanish Association of Pancreatology and the Spanish Association of Gastroenterology, with the aim of promoting basic and clinical research in pancreatic cancer. They are made possible thanks to the public's participation in the Carrera de las Ciudades contra el Cáncer de Páncreas (Cities Race Against Pancreatic Cancer), which in 2025 reached its tenth edition.
Més informació "Carmen Delgado/Miguel Pérez Mateo Grant for Dr José Yélamos López"
11/11/2025 - General information
Dr. Anna Bigas, coordinator of the Stem Cells and Cancer Research Group at the Hospital del Mar Research Institute and the Josep Carreras Leukaemia Research Institute, has just joined the journal Development as an Associate Editor. The journal is published by The Company of Biologists, a non-profit organization led by leading scientists in the field. This is one of the reference publications in its area. Dr. Bigas will be responsible for evaluating and deciding on the publication of studies related to the development of hematopoietic stem cells and how their deregulation contributes to the onset of blood diseases.
Més informació "Dr. Anna Bigas begins a new chapter as Associate Editor of the journal Development"
04/11/2025 - General information
The Pharmacokinetics and Pharmacodynamics (PK/PD) Research Team at Hospital del Mar has received a competitive international grant awarded by the pharmaceutical company Pfizer, as part of the "Independent Research Grant Program - Pharmacokinetics-pharmacodynamics (PK/PD) of Aztreonam-Avibactam (ATM-AVI) in Special Populations." The selected project, chosen among proposals from several European centers, aims to optimize the use of the new antibiotic aztreonam-avibactam in patients with renal impairment - a population particularly vulnerable to severe infections caused by multidrug-resistant bacteria. The project is led by Dr. Mila Montero and Dr. Sònia Luque.
Més informació "Pfizer International Grant for a Project at Hospital del Mar on Antibiotic Therapy"
22/10/2025 - General information
The Hemodynamics Unit of the Cardiology Department at Hospital del Mar took part in a study published in the New England Journal of Medicine. The study demonstrates that one month after undergoing treatment for a myocardial infarction, patients can safely continue therapy with a single antiplatelet drug without added risk.
30/09/2025 - General information
On October 4, from 10:00 to 14:30 h, a new edition of the Open Day at the Barcelona Biomedical Research Park (PRBB) will take place, where researchers will explain first-hand what they do, how they do it, and where they do it. Come and discover a major scientific infrastructure where the different research centers that are part of the PRBB will offer a wide variety of free activities for the whole family.
Més informació "OPEN PRBB 2025: On Saturday, October 4, we open our doors again!"
23/09/2025 - General information
The "la Caixa" Foundation has announced the results of the 2025 CaixaImpulse call, which supports 31 biomedical projects from research centers, hospitals, and universities in Spain and Portugal. Among them is the project led by Dr. Aura Muntasell, aimed at developing a ready-to-use cell therapy to more effectively combat cancer.
28/08/2025 - General information
Research led by CIBER-ISCIII, within the framework of the PREDIMED-Plus study, describes how a low-calorie Mediterranean diet combined with physical exercise reduces the risk of diabetes, confirming the joint benefit of both lifestyle approaches in preventing this disease. The study received over 15 million euros in funding, mainly from the ISCIII and the CIBER Consortium, and involved three CIBER research areas and more than 200 specialists from 23 research centers, including the Hospital del Mar Research Institute.
02/07/2025 - General information
Levels of butyrate and isobutyrate, short-chain fatty acids produced by the gut microbiota, are associated with a higher risk of developing the disease, according to a study led by IISPV and Hospital del Mar. A research team led by scientists from the Pere Virgili Health Research Institute (IISPV), the Hospital del Mar Research Institute, and the Diabetes and Associated Metabolic Diseases area of the CIBER (CIBERDEM) has identified two compounds present in the blood - butyrate and isobutyrate - that could serve as early predictors of type 2 diabetes in seemingly healthy individuals.
Servei de Comunicació:
Marta Calsina(ELIMINAR)
Tel:
(+34) 93 316 06 80
Doctor Aiguader, 88
08226 Barcelona
© Institut Hospital del Mar
d'Investigacions MèdiquesLegal Notice and Privacy Policy | Cookie Policy | Site Index | Accessibility | Find Us | Contact
